| abstract |
The present invention provides a novel crystalline phase of (3S, 3S ') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) (ABSD) and L-lysine, and especially its use in the pharmaceutical industry. , And a method for manufacturing the same. The present invention also provides pharmaceutical compositions containing (3S, 3S ') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) (ABSD) and one or more crystalline phases of L-lysine, and It relates to the therapeutic or prophylactic use of the crystalline phase and compositions comprising the same. |